2025 年 10 月 9 日，国庆假期后的头个交易日，港股医药市场呈现出鲜明的分化格局：石四药集团、同仁堂国药等企业逆势上涨，其中石四药集团大涨 3.12%；而诺诚健华、科伦博泰生物 - B 等创新药企则出现不同程度下跌，诺诚健华跌幅达 11.75%。这种看似矛盾的市场表现，实则折射出创新药板块在短期调整与长期机遇中的微妙平衡。就在近日，辉瑞协议解除海外 MNC 政策担忧的消息为市场注入强心剂，...
Source Link2025 年 10 月 9 日，国庆假期后的头个交易日，港股医药市场呈现出鲜明的分化格局：石四药集团、同仁堂国药等企业逆势上涨，其中石四药集团大涨 3.12%；而诺诚健华、科伦博泰生物 - B 等创新药企则出现不同程度下跌，诺诚健华跌幅达 11.75%。这种看似矛盾的市场表现，实则折射出创新药板块在短期调整与长期机遇中的微妙平衡。就在近日，辉瑞协议解除海外 MNC 政策担忧的消息为市场注入强心剂，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.